SCHEMBL4894652

SCHEMBL4894652

Cc1ccc(S(=O)(=O)NCCc2ccc(Oc3ccc(C(F)(F)F)cc3)cc2)cc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
AKR1C3 P42330 3/20 0.48
LTA4H P09960 1/20 0.47
EPHX2 P34913 1/20 0.47
POLB P06746 2/20 0.47
MAPK1 P28482 2/20 0.47
PKM P14618 1/20 0.47
HTT P42858 1/20 0.47
TP53 P04637 2/20 0.46
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAPT P10636 3/20 0.45
RECQL P46063 1/20 0.45
MCL1 Q07820 1/20 0.44
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906499 0.92 ALDH1A1 (0.48) LMNAAKR1C3LTA4HEPHX2POLB
SCHEMBL4905297 0.91 ADAMTS4 (0.50) LMNAAKR1C3POLBMAPK1PKM
SCHEMBL4907127 0.91 LMNA (0.51) LMNAAKR1C3LTA4HEPHX2POLB
SCHEMBL4903705 0.91 LMNA (0.53) LMNAAKR1C3MAPK1PKMHTT
SCHEMBL4903155 0.89 AKR1C3 (0.48) LMNAAKR1C3LTA4HEPHX2POLB
SCHEMBL4906290 0.89 LTA4H (0.47) AKR1C3LTA4HEPHX2POLBMAPK1
SCHEMBL4899418 0.89 ALDH1A1 (0.58) LMNAAKR1C3POLBTP53ALDH1A1
SCHEMBL4902642 0.89 LMNA (0.60) LMNAAKR1C3POLBTP53ALDH1A1
SCHEMBL4904125 0.88 LMNA (0.50) LMNAAKR1C3POLBMAPK1PKM
SCHEMBL4907073 0.88 HTT (0.60) LMNAAKR1C3POLBMAPK1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885AKR1C3 1645/4885LTA4H 2962/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885AKR1C3 1645/4885LTA4H 2962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.